Condition

Carcinoma, Non-Small-Cell Lung (NSCLC)

ClinicalTrials.gov condition label

Explore related research

Search across original and mapped records

Search results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 10 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials10
Recruiting6
Common interventions18
Lead sponsors shown7
Advertisement

Clinical trials

10 shown
Multicenter, Single-Arm, Prospective Phase II Study of Neoadjuvant Cryo-Thermal Ablation Combined With Toripalimab and Chemotherapy for Resectable Stage IB-IIIB Non-Small Cell Lung CancerNCT07855965 · 2026-09-10
RECRUITING
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLCNCT07489066 · 2026-06-30
RECRUITING
Vortioxetine for Cognitive Function in ALK-positive NSCLC Treated With LorlatinibNCT07633626 · 2026-03-10
RECRUITING
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung CancerNCT07222566 · 2026-01-06
RECRUITING
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.NCT06758401 · 2025-07-23
RECRUITING
Prospective Cohort Study Evaluating 18FDG PET-CT for the Early Prediction of the Efficacy of Immunotherapy Associated or Not With Chemotherapy in Patients With Locally Advanced or Metastatic Non-Small Cell Broncho-Pulmonary CarcinomaNCT06833229 · 2022-01-27
RECRUITING
Primary Radiotherapy In MEtastatic Lung CancerNCT07135882 · 2026-08-25
NOT_YET_RECRUITING
Intermittent Hypoxic Training as Neoadjuvant Therapy for Lung Squamous Cell CarcinomaNCT07618793 · 2026-06-01
NOT_YET_RECRUITING
Iparomlimab and Tuvonralimab Plus Chemotherapy Before Surgery for Stage III Lung CancerNCT07538193 · 2026-05-01
NOT_YET_RECRUITING
Trial Of AG-013736, Cisplatin, And Gemcitabine For Patients With Squamous Non-Small Cell Lung CancerNCT00735904 · 2008-12-01
COMPLETED

Common interventions

Trial status mix

RECRUITING6
NOT_YET_RECRUITING3
COMPLETED1

Phase mix

PHASE24
PHASE33
NA1
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.